Long-Term Outcomes From a Randomized Dose Optimization Study of Chimeric Antigen Receptor Modified T Cells in Relapsed Chronic Lymphocytic Leukemia

To describe long-term outcomes of anti-CD19 chimeric antigen receptor T (CART) cells in patients with relapsed or refractory chronic lymphocytic leukemia (CLL). METHODS: Between January 2013 and June 2016, 42 patients with relapsed or refractory CLL were enrolled in this study and 38 were infused wi...

詳細記述

保存先:
書誌詳細
出版年:J Clin Oncol
主要な著者: Frey, Noelle V., Gill, Saar, Hexner, Elizabeth O., Schuster, Stephen, Nasta, Sunita, Loren, Alison, Svoboda, Jakub, Stadtmauer, Edward, Landsburg, Daniel J., Mato, Anthony, Levine, Bruce L., Lacey, Simon F., Melenhorst, Jan Joseph, Veloso, Elizabeth, Gaymon, Avery, Pequignot, Edward, Shan, Xinhe, Hwang, Wei-Ting, June, Carl H., Porter, David L.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Clinical Oncology 2020
主題:
ORIGINAL REPORTS
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265376/
https://ncbi.nlm.nih.gov/pubmed/32298202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.03237
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料